Roll out of Cambridge-developed artificial pancreas is world first
An artificial pancreas developed with the help of staff and patients at Addenbrooke's Hospital is one of four new devices to be rolled out by the NHS - helping tens of thousands of children and adults living with type one diabetes.
The ground-breaking device - pioneered by Cambridge-based Professor Roman Hovorka and called the CamAPS FX app - continually monitors a person's blood glucose, then automatically adjusts the amount of insulin given to them through a pump.
It is the only device that has been fully developed in the UK and the only one suitable for women who are pregnant.
Professor Hovorka said:
"It is very exciting that a device developed in Cambridge with the help of local experts and local people will now become accessible to patients all over the country"
"It will enable them to spend less time having to focus on managing their condition and worrying about the blood sugar levels, and more time getting on with their lives"
For more information visit: CUH News
Published April 5 2024
Latest from CCTU
Targeting the immune system could prevent future heart attacks, Cambridge-led trial suggests
Cambridge researchers have discovered that an existing therapy which boosts protective immune cells in people who have recently had heart attacks reduces…
Cambridge study finds hot flush treatment has anti-breast cancer activity
A drug mimicking the hormone progesterone has anti-cancer activity when used together with conventional anti-oestrogen treatment for women with breast…
Innovative trial offers hope on World Pancreatic Cancer Day
An early-stage trial, recently opened at Addenbrooke's Hospital, offers new hope to people with late-stage pancreatic cancer and their families.
…
